LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,980,564 | +1.8% | 2,000,000 | 0.0% | 0.14% | +13.0% |
| Q4 2022 | $1,946,251 | +0.6% | 2,000,000 | 0.0% | 0.12% | -5.4% |
| Q3 2022 | $1,935,000 | +1.0% | 2,000,000 | 0.0% | 0.13% | +8.3% |
| Q2 2022 | $1,916,000 | -1.3% | 2,000,000 | 0.0% | 0.12% | +13.2% |
| Q1 2022 | $1,942,000 | -22.0% | 2,000,000 | -20.0% | 0.11% | -27.4% |
| Q4 2021 | $2,490,000 | -0.6% | 2,500,000 | 0.0% | 0.15% | -3.3% |
| Q3 2021 | $2,504,000 | +1.3% | 2,500,000 | 0.0% | 0.15% | -5.6% |
| Q2 2021 | $2,471,000 | -33.7% | 2,500,000 | -30.6% | 0.16% | -40.5% |
| Q1 2021 | $3,726,000 | +10.0% | 3,600,000 | 0.0% | 0.27% | +11.2% |
| Q4 2020 | $3,388,000 | +66.9% | 3,600,000 | +60.0% | 0.24% | +38.3% |
| Q3 2020 | $2,030,000 | -28.8% | 2,250,000 | -30.8% | 0.18% | -30.0% |
| Q2 2020 | $2,850,000 | -13.7% | 3,250,000 | -18.8% | 0.25% | -14.1% |
| Q1 2020 | $3,303,000 | -32.9% | 4,000,000 | -29.8% | 0.29% | -11.0% |
| Q4 2019 | $4,919,000 | +14.6% | 5,700,000 | +10.7% | 0.33% | +4.8% |
| Q3 2019 | $4,291,000 | -11.3% | 5,150,000 | -8.0% | 0.31% | -13.1% |
| Q2 2019 | $4,835,000 | – | 5,600,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|